# The Context of COVID-19 at 18 Months in Relation to Depression, Anxiety, Insomnia: The Emerging Role of Post COVID-19 Symptoms

**Authors:** Karin C. Brocki, Monica Buhrman, Farzaneh Badinlou, Lance M. McCracken

PMC · DOI: 10.32872/cpe.13243 · Clinical Psychology in Europe · 2025-08-29

## TL;DR

Eighteen months into the pandemic, mental health issues like depression and insomnia remain common in Sweden, with many people experiencing long-term symptoms linked to COVID-19.

## Contribution

This study identifies persistent mental health symptoms and their risk factors in the late pandemic phase, emphasizing the role of post-COVID conditions.

## Key findings

- Mental health issues like depression and insomnia remained elevated 18 months into the pandemic.
- Persistent post-COVID symptoms were reported by 84.5% of participants, with 49.7% linking them to COVID-19.
- A history of poor mental health and pandemic-related worries were key risk factors for mental health problems.

## Abstract

The COVID-19 pandemic naturally raised concerns about mental health and wellbeing around the world. As time passed, persisting physical and mental symptoms of post COVID-19, referred to as Post COVID Condition (PCC), have become an increasing concern. The aim of this study was to investigate the stability of symptoms of mental ill health in Sweden in the late phase of the pandemic and the prevalence of persistent symptoms post COVID-19 and interrelations between them.

We measured depression, anxiety, and insomnia, through a one-time online survey in Sweden (n = 1,482, mean age 47.6 years; 89.5% women) and used correlation and regression analysis to study potential predictors and their interrelations with PCC symptoms.

Compared to our previous study during the pandemic (May – June 2020), a marginal decrease was found for depression (27% versus 30%), a larger decrease for anxiety (16% vs 24%), and an increase for insomnia (45% vs 38%). Persistent symptoms were frequently reported, with 84.5% reporting at least one symptom, and 49.7% attributing one or more of these to COVID-19 infection. A history of poor mental health and COVID-19 related worry appeared as the strongest risk factors for mental ill health. Persistent symptoms also predicted these outcomes.

Based on comparison with pre-pandemic rates, it appears that the pandemic continued to exert a negative impact on mental health in Sweden. Persistent symptoms, associated with COVID-19 exposure, appear common and may represent a vulnerability factor for mental ill health, along with other factors, including history of a mental ill health and specific pandemic worries.

Mental health problems persist 18 months post-pandemic.High rates of depression, anxiety, and insomnia are documented.Symptoms of Post COVID-19 Condition appear highly prevalent, notably fatigue.Risk factors for persistent symptoms include health history and pandemic-related worries.

Mental health problems persist 18 months post-pandemic.

High rates of depression, anxiety, and insomnia are documented.

Symptoms of Post COVID-19 Condition appear highly prevalent, notably fatigue.

Risk factors for persistent symptoms include health history and pandemic-related worries.

## Linked entities

- **Diseases:** depression (MONDO:0002050), anxiety (MONDO:0005618), insomnia (MONDO:0013600), COVID-19 (MONDO:0100096)

## Full-text entities

- **Diseases:** Anxiety (MESH:D001007), decreased lung function (MESH:D055370), angina (MESH:D000787), impaired daily functioning (MESH:D020773), diabetes (MESH:D003920), cancer (MESH:D009369), mental ill (MESH:D001523), breathing problems (MESH:D004417), Insomnia (MESH:D007319), quality (MESH:D012893), respiratory disease (MESH:D012140), reduced sense of taste (MESH:D013651), headache (MESH:D006261), reduced sense of smell (MESH:D000857), fever (MESH:D005334), stroke (MESH:D020521), chest pain (MESH:D002637), fatigue (MESH:D005221), nausea (MESH:D009325), Mental health problems (MESH:D000076082), mental health (OMIM:603663), joint pain (MESH:D018771), cough (MESH:D003371), weight loss (MESH:D015431), psychological disturbances (MESH:D000067073), COVID (MESH:D000086382), attention problems (MESH:D001289), infected (MESH:D007239), hypertension (MESH:D006973), mental (MESH:D008607), Generalized Anxiety Disorder (MESH:C000726808), sore throat (MESH:D010612), PCC (MESH:D000094024), difficulties with memory (MESH:D008569), cognitive disturbance (MESH:D003072), tract (MESH:D014570), gut problems (MESH:D019973), mental health condition (MESH:D000071069), Appetite (MESH:D001068), dysfunctions (MESH:D006331), Depression (MESH:D003866)
- **Species:** Severe acute respiratory syndrome coronavirus 2 (no rank) [taxon 2697049], Gammacoronavirus (genus) [taxon 694013], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12923178/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12923178/full.md

## References

30 references — full list in the complete paper: https://tomesphere.com/paper/PMC12923178/full.md

---
Source: https://tomesphere.com/paper/PMC12923178